These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1545154)

  • 21. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents.
    Pedersen-Bjergaard J; Janssen WG; Lyons J; Philip P; Bartram CR
    Cancer Res; 1988 Apr; 48(7):1812-7. PubMed ID: 3280121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low incidence of point mutation of N-ras oncogene in human gliomas].
    Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
    No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
    Collins SJ
    Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient.
    Speletas M; Arvanitidi K; Tzoanopoulos D; Tsironidou V; Pardali E; Aggeli C; Tsapogas P; Kartalis G; Sideras P; Ritis K
    Haematologica; 2001 Sep; 86(9):918-27. PubMed ID: 11532619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the c-myc and N-ras genes in acute myelogenous leukemia cells which manifest the constitutive expression of the c-myc gene.
    Kadam P; Steele P; Li YQ; Preisler H
    Anticancer Res; 1993; 13(3):747-51. PubMed ID: 8317907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.
    Tidow N; Pilz C; Kasper B; Welte K
    Stem Cells; 1997; 15 Suppl 1():113-9; discussion 120. PubMed ID: 9368331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
    Jacobson DR; Mills NE
    Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete sequence analysis of mitochondrial DNA of aplastic anemia patients.
    Cui X; Liu F; Wang JQ; Zhang WJ; Wang JY; Liu K; Cui SY; Zhang J; Xu RR
    Genet Mol Res; 2012 Aug; 11(3):2130-7. PubMed ID: 22911596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia.
    Todd AV; Ireland CM; Iland HJ
    Leukemia; 1991 Feb; 5(2):160-1. PubMed ID: 2020198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dot hybridization with synthetic oligonucleotide; analysis of point mutation of c-ras genes].
    Nagata Y; Shiku H
    Nihon Rinsho; 1990 Aug; 48(8):163-9. PubMed ID: 2255077
    [No Abstract]   [Full Text] [Related]  

  • 34. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia.
    Browne PV; Lawler M; Humphries P; McCann SR
    N Engl J Med; 1991 Sep; 325(10):710-3. PubMed ID: 1870642
    [No Abstract]   [Full Text] [Related]  

  • 35. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
    Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
    Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
    Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
    Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of N-RAS point mutations in peripheral blood cells of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinurea.
    White JR; Josten KM; Chopra R; Tooze J; Saso R; Gordon-Smith EC; Rutherford TR
    Br J Haematol; 1995 Dec; 91(4):921-3. PubMed ID: 8547140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase mutations in aplastic anemia.
    Fibbe WE
    N Engl J Med; 2005 Apr; 352(14):1481-3. PubMed ID: 15814885
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of heteroplasmic mutations in the mitochondrial genome and the ID4 gene promoter methylation region in the pathogenesis of chronic aplastic anemia in patients suffering from Kidney yin deficiency.
    Cui X; Wang JY; Liu K; Cui SY; Zhang J; Luo YQ; Wang X
    Chin J Integr Med; 2016 Jun; 22(6):412-9. PubMed ID: 25920536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of polymerase chain reaction to detect activated oncogenes in hematological malignancies.
    Ishikawa F; Kobayashi Y
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1433-41. PubMed ID: 2629464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.